MarketInOut Stock Screener Log In | Sign Up
 

Santen Pharmaceutical Co Ltd ADR

OTC • Healthcare • Drug Manufacturers - General • Quote as of 05/08/2026
Santen Pharmaceutical Co Ltd ADR stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeOTC
Market Capitalization3,322.96 mln
Float322 mln
Earnings Date05/12/2026

EPS

0.58
Moderate

P / E

18.43
Moderately valued

Piotroski F-Score

7 / 9
Strong

Beneish M-Score

-2.35
Borderline

Relative Strength

64 / 100
Outperforming

Debt / Equity

0.00
Debt-free

Business Description

Santen Pharmaceutical is a Japanese company founded in 1890 and headquartered in Osaka, with operations spanning Asia, Europe, the Middle East, Africa, and beyond. The company focuses exclusively on eye care, developing and selling medicines and medical devices to treat conditions such as glaucoma, dry eye, allergic eye disease, and other vision-related disorders. Its portfolio includes both established treatments and a active pipeline of new drugs currently undergoing late-stage clinical trials.

Key Fundamentals

EPS0.58
P/E18.43
ROE10.90
RPS5.73
ROIC10.66
ROA7.66
Interest Cover13.74
EBITDA, mln349
EV / EBITDA8.28
EV / EBIT10.02
Revenue, mln1,929
EV / Revenue1.50

Financial Strength

Altman Z-Score4.89
Piotroski F-Score 7 / 9
Beneish M-Score-2.35
Price to Intrinsic Value1.12
Price to Lynch Fair Value1.03
Price to Graham Number1.42
Shiller PE Ratio27.31

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 6.63% 78 / 100   
1 Month -10.51% 18 / 100   
2 Months -4.98% 40 / 100   
6 Months 8.61% 53 / 100   
1 Year 9.67% 43 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us